Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 15 matching records.
15 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Synthetic and Natural Agents Targeting Advanced Glycation End-Products for Skin Anti-Aging: A Comprehensive Review of Experimental and Clinical Studies
Narrative Review on Tendon Injury, Skin Aging, published in Antioxidants (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
Antioxidants (Basel)6 citations - Level DNarrative ReviewEurope PMC
Advanced Glycation End Products in Disease Development and Potential Interventions
Narrative Review on Neuroinflammation, Chronic Inflammation, published in Antioxidants (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
Antioxidants (Basel)39 citations - Level DNarrative ReviewPubMed
Effects of advanced glycation end products on stem cell.
Narrative Review on Neuroinflammation, published in Front Cell Dev Biol (2024) — summary generated from the PubMed abstract.
- 2024
Front Cell Dev Biol - Level DNarrative ReviewEurope PMC
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy
Narrative Review on Systemic / IV, published in Endocr Rev (2023) — summary generated from the PubMed abstract.
- 2023
Endocr Rev38 citations - Level ASystematic ReviewEurope PMC
Effects of advanced glycation end products (AGEs) on the differentiation potential of primary stem cells: a systematic review
Systematic Review on Chronic Kidney Disease, Chronic Inflammation, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther17 citations - Level DNarrative ReviewEurope PMC
Receptor for the Advanced Glycation End Products ( RAGE ) Pathway in Adipose Tissue Metabolism
Narrative Review on Type 2 Diabetes, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci24 citations - Level DLaboratory StudyEurope PMC
Advanced Glycation End Products Impair Cardiac Atrial Appendage Stem Cells Properties
Laboratory Study on Cardiovascular Disease, published in J Clin Med (2021) — summary generated from the PubMed abstract.
- 2021
J Clin Med4 citations - Level DNarrative ReviewEurope PMC
Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression
Narrative Review, published in J Clin Med (2021) — summary generated from the PubMed abstract.
- 2021
J Clin Med12 citations - Level DAnimal StudyPubMed
Advanced glycation end products inhibit the osteogenic differentiation potential of adipose-derived stem cells by modulating Wnt/β-catenin signalling pathway via DNA methylation.
Animal Study on Systemic / IV, published in Cell Prolif (2020) — summary generated from the PubMed abstract.
- 2020
Cell Prolif52 citations - Level ASystematic ReviewEurope PMC
The Impact of Advanced Glycation End-Products (AGEs) on Proliferation and Apoptosis of Primary Stem Cells: A Systematic Review
Systematic Review, published in Stem Cells Int (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cells Int11 citations - Level DLaboratory StudyPubMed
Advanced Glycation End-Products-, C-Type Lectin- and Cysteinyl/ Leukotriene-Receptors in Distinct Mesenchymal Stromal Cell Populations: Differential Transcriptional Profiles in Response to Inflammation.
Laboratory Study, published in Cell J (2018) — summary generated from the PubMed abstract.
- 2018
Cell J - Level DAnimal StudyPubMed
Blockade of receptors of advanced glycation end products ameliorates diabetic osteogenesis of adipose-derived stem cells through DNA methylation and Wnt signalling pathway.
Animal Study on Systemic / IV, published in Cell Prolif (2018) — summary generated from the PubMed abstract.
- 2018
Cell Prolif47 citations - Level DLaboratory StudyPubMed
[Effect of advanced glycation end products on the function and angiogenesis of adipose tissue-derived stem cells and the protective effect of danhong injection: an experimental study].
Laboratory Study, published in Zhongguo Zhong Xi Yi Jie He Za Zhi (2014) — summary generated from the PubMed abstract.
- 2014
Zhongguo Zhong Xi Yi Jie He Za Zhi2 citations - Level CProspective StudyPubMed
Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.
Prospective Study on Chronic Wound, published in J Bone Miner Res (2005) — summary generated from the PubMed abstract.
- 2005
J Bone Miner Res - Level CProspective StudyPubMed
Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.
Prospective Study on Systemic / IV, published in Med Hypotheses (2005) — summary generated from the PubMed abstract.
- 2005
Med Hypotheses
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406